SI
ACAD icon

Sofinnova Investments’s Acadia Pharmaceuticals ACAD Stock Holding History

Sofinnova Investments’s Portfolio ACAD Stock Details ACAD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.75M Buy
78,551
+12,984
+20% +$310K 0.09% 65
2025
Q4 		$1.75M Buy
65,567
+38,767
+145% +$926K 0.08% 56
2025
Q3 		$572K Buy
+26,800
New +$634K 0.04% 60
2025
Q2 		– Hold
0
– – – 65
2025
Q1 		– Hold
0
– – – 66
2021
Q3 		– Hold
0
– – – 72
2021
Q2 		– Hold
0
– – – 68
2021
Q1 		– Sell
-164,625
Closed -$8.8M – 66
2020
Q4 		$8.8M Buy
164,625
+115,629
+236% +$5.74M 0.55% 38
2020
Q3 		$2.02M Buy
+48,996
New +$2.12M 0.16% 61
2019
Q3 		– Sell
-155,576
Closed -$4.16M – 73
2019
Q2 		$4.16M Buy
+155,576
New +$3.97M 0.39% 43

Other funds holding ACAD

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return